Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

Delayed Quote. Delayed  - 05/27 09:59:59 pm
12.42 USD   +5.70%
05/18 SUCAMPO PHARMAC : Announces Webcast of Its Presentation at the 2016 ..
05/17 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at ..
05/04 SUCAMPO PHARMAC : reports 1Q loss
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
11.55(c) 11.86(c) 11.79(c) 11.75(c) 12.42(c) Last
277 230 351 104 367 193 243 123 490 473 Volume
-0.35% +2.68% -0.59% -0.34% +5.70% Change
More quotes
Financials ($)
Sales 2016 204 M
EBIT 2016 83,7 M
Net income 2016 31,6 M
Debt 2016 141 M
Yield 2016 -
Sales 2017 227 M
EBIT 2017 106 M
Net income 2017 63,4 M
Debt 2017 87,4 M
Yield 2017 -
P/E ratio 2016 16,10
P/E ratio 2017 8,25
EV / Sales 2016 3,34x
EV / Sales 2017 2,75x
Capitalization 538 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
05/18 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 2016 UBS ..
05/17 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 UBS..
05/12 VEEVA SYSTEMS : Sucampo Standardizes on Veeva Vault for a Single Source of Truth..
05/05 SUCAMPO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
05/04 SUCAMPO PHARMACEUTICALS : reports 1Q loss
05/04 SUCAMPO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, R..
05/04 Sucampo Reports Strong Results for First Quarter of 2016
05/03 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of ..
04/20 SUCAMPO PHARMACEUTICALS : Reports Top-Line Data from Phase 2a Study of Cobiprost..
04/20 Sucampo Announces First Quarter 2016 Earnings Call
More news
Sector news : Bio Therapeutic Drugs
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Bio Therapeutic Drugs
4-Traders Strategies on SUCAMPO PHARMACEUTICALS, I 
2015The bullish trend is not over
More Strategies
News from SeekingAlpha
05/04 Sucampo Pharmaceuticals' (SCMP) CEO Peter Greenleaf on Q1 2016 Results - Earn..
05/04 Sucampo beats by $0.02, beats on revenue
05/03 Notable earnings before Wednesday?s open
04/26 HEDGED RELYPSA LONGS : Consider This Course Correction
04/22 Healthcare ratings roundup
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends SUCAMPO PHARMACEU...
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions